Cite
HARVARD Citation
Colombo, N. et al. (n.d.). 16/#430 Phase 2 results of relacorilant + nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer with and without prior bevacizumab. International journal of gynecological cancer. pp. A32-A33. [Online].